However, as tariffs phase instarting Aug 1, 2025, and possibly reaching 200% on APIsthese added costs for brand name NDT drugs will eventually affect insurance reimbursements and copays
What actual patients report about results and side effects
Where GHRP-6 still wins Despite being a first-generation compound, GHRP-6 retains several unique advantages: 1
In addition to residual cardiovascular risk despite aggressive LDL reduction, high costs limiting accessibility, and unresolved long-term safety concerns, past failures of HDL-directed therapies such as CETP inhibitors underscore the complexity of lipid biology
The primary goal here is tolerability, not maximum weight loss
Coinsurance: A percentage of the costs you must pay after youve met your deductible